The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes with definitive local treatment to the primary site in non-nasopharyngeal head and neck squamous cell carcinoma patients with synchronous distant metastasis.
 
Steven Borson
No Relationships to Disclose
 
Yongli Shuai
No Relationships to Disclose
 
Barton Branstetter
No Relationships to Disclose
 
Marci Lee Nilsen
No Relationships to Disclose
 
Marion Hughes
No Relationships to Disclose
 
Mark Kubik
No Relationships to Disclose
 
Shaum Sridharan
No Relationships to Disclose
 
David Anthony Clump
No Relationships to Disclose
 
Heath Devin Skinner
No Relationships to Disclose
 
Jonas T. Johnson
No Relationships to Disclose
 
Simion I. Chiosea
No Relationships to Disclose
 
James Ohr
No Relationships to Disclose
 
Umamaheswar Duvvuri
No Relationships to Disclose
 
Seungwon Kim
No Relationships to Disclose
 
Katie Traylor
No Relationships to Disclose
 
Moon Jung Fenton
No Relationships to Disclose
 
Robert L. Ferris
Stock and Other Ownership Interests - Novasenta
Consulting or Advisory Role - Aduro Biotech; Bristol-Myers Squibb; EMD Serono; Macrogenics; Merck; Novasenta; Numab; Pfizer; Sanofi; Zymeworks
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck; Novasenta; Tesaro
 
Dan Paul Zandberg
Research Funding - Aduro Biotech (Inst); Astellas Medivation (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); ISA Pharmaceuticals (Inst); Merck (Inst); Regeneron (Inst)